Engineered peptides show promise in cancer immunotherapy : c

In a new study published today in Nature Biomedical Engineering, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.

Related Keywords

Texas , United States , Owen Jiang , Betty Kim , University Of Texas Md Anderson Cancer Center , National Cancer Institute , Us Department Of Defense , Manderson Cancer , Nature Biomedical Engineering , Cancer Center , Immunotherapy , Breast Cancer , Dancer , Drugs , Immune Response , Immune System , Eptides , Mh , Reclinical , Research , Humor ,